Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 3 of 8 | Showing Results 11 - 15 of 36

TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the...

Elisabeth Lucassen, M.D.
  • Providence St. Vincent Medical Center

A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis

Inclusion Criteria:-Aged 18-60 years-Meets 2017 McDonald criteria for relapsing-remitting MS [patients with clinically isolated syndrome (CIS) are...

Peiqing Qian, M.D.
  • Swedish Medical Center

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.

Inclusion Criteria:Able to understand the purpose and risk of the study and provide signed informed consent document.Must have received 12 or more...

Hui-Juan Zhang, M.D.
  • Kadlec Neuroscience Center
  • Kadlec Research

Feasibility of the multiple sclerosis performance test for assessment of functional performance measures in patients with multiple sclerosis

Key Inclusion Criteria:-Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to...

Kyle E Smoot, M.D.
  • Providence St. Vincent Medical Center

BIP - Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab

The primary objective of this study is to assess the efficacy of Ocrelizumab (OCR) in Relapsing Multiple Sclerosis patients who have been...

Kyle E Smoot, M.D.
  • Providence St. Vincent Medical Center
  • St. Barnabas Medical Center
  • Swedish Medical Center
Viewing Page 3 of 8 | Showing Results 11 - 15 of 36